Dynamic Albumin Values as Clinical Surrogate for Covid-19 Therapeutics

Abstract

Get full access to this article

View all access options for this article.

References

Batth

. Correlation of rate of serum albumin decline with other acute phase reactants and effect of current treatment options on serum albumin level in COVID-19. J Investig Med.

van Zyl

, Alam

, Felius

, . ALLY in fighting COVID-19: magnitude of albumin decline and lymphopenia (ALLY) predict progression to critical disease. J Investig Med 2021;69:710–8.doi:10.1136/jim-2020-001525http://www.ncbi.nlm.nih.gov/pubmed/33431604

RECOVERY Collaborative Group, Horby

, Lim

, . Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021;384:693–704.doi:10.1056/NEJMoa2021436http://www.ncbi.nlm.nih.gov/pubmed/32678530